Stifel Financial Corp Sells 21,794 Shares of Tilray Inc (NASDAQ:TLRY)

Stifel Financial Corp trimmed its position in Tilray Inc (NASDAQ:TLRY) by 21.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 81,018 shares of the company’s stock after selling 21,794 shares during the period. Stifel Financial Corp’s holdings in Tilray were worth $143,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Point72 Asset Management L.P. bought a new stake in Tilray in the 3rd quarter valued at approximately $1,348,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Tilray by 6.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,677,899 shares of the company’s stock worth $2,953,000 after purchasing an additional 107,530 shares in the last quarter. CreativeOne Wealth LLC bought a new stake in shares of Tilray in the third quarter worth $127,000. BNP Paribas Financial Markets boosted its holdings in Tilray by 1,314.1% during the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after purchasing an additional 1,690,827 shares during the last quarter. Finally, The Manufacturers Life Insurance Company grew its position in Tilray by 4.9% in the third quarter. The Manufacturers Life Insurance Company now owns 715,672 shares of the company’s stock valued at $1,260,000 after purchasing an additional 33,194 shares in the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Roth Mkm cut their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research report on Friday, October 11th.

Insiders Place Their Bets

In other Tilray news, CFO Carl A. Merton purchased 26,000 shares of the business’s stock in a transaction on Friday, November 15th. The stock was acquired at an average price of $1.36 per share, with a total value of $35,360.00. Following the acquisition, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at $35,360. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.87% of the company’s stock.

Tilray Trading Down 4.9 %

NASDAQ TLRY opened at $1.36 on Tuesday. The company has a market cap of $1.23 billion, a PE ratio of -5.04 and a beta of 2.08. Tilray Inc has a 12 month low of $1.14 and a 12 month high of $2.97. The stock has a 50 day moving average of $1.42 and a 200-day moving average of $1.64. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting analysts’ consensus estimates of ($0.04). The company had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The company’s quarterly revenue was up 13.0% on a year-over-year basis. During the same quarter last year, the firm posted ($0.10) EPS. On average, equities research analysts anticipate that Tilray Inc will post -0.14 EPS for the current fiscal year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.